Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification
Status:
Recruiting
Trial end date:
2020-10-30
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to compare the efficacy of antecedent intravitreal
anti-vascular endothelial growth factor therapy vs. Ozurdex in reducing post-cataract surgery
related macular edema in patients with pre-existing diabetic macular edema.